Federal contractor · BOSTON, MA

DANA-FARBER CANCER INSTITUTE, INC.

DANA-FARBER CANCER INSTITUTE, INC. received $933K in federal contract obligations in FY2026, on 1 awards. Since FY2017: $1.3M. Its largest customer was Food and Drug Administration ($933K). It also received $189.2M in federal grants and other assistance in FY2026.

Obligations · FY2026
$933K
New awards
1
Sole-source
0.0%
Single offer
100%
UEI
DPMGH9MG1X67
Other than small businessNonprofit

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. -12.2KFY2017
  2. -35.6KFY2018
  3. 62.8KFY2019
  4. 261.6KFY2020
  5. 88.3KFY2021
  6. 49KFY2022
  7. -25KFY2025
  8. 933KFY2026

Top buying agencies

Obligations in FY2026.

  1. 1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Research & development$933K100%

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition100%
    US 39% · $933K
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions100%
    US 8.7% · $933K
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. Food and Drug Administration· Montgomery County, MD· Research & development· Sep 25, 2026 – Sep 25, 2026· 75F40126C00068

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

DANA-FARBER CANCER INSTITUTE, INC. received $189.2M in federal assistance in FY2026, on 435 actions (57 new awards), +4.3% vs FY2025. Its largest program was 93.395 · Cancer Treatment Research ($41.7M).

Assistance · FY2026
$189.2M
New awards
57
Actions
435
Since FY2021
$1.1B

Assistance by fiscal year

  1. 181.1MFY2021
  2. 173MFY2022
  3. 184.6MFY2023
  4. 187.8MFY2024
  5. 181.5MFY2025
  6. 189.2MFY2026

By type

  1. Grants$185.8M98%
  2. Direct payments$3.4M1.8%

Top programs

  1. 93.395 · Cancer Treatment Research$41.7M22%
  2. 93.393 · Cancer Cause and Prevention Research$30.3M16%
  3. 93.397 · Cancer Centers Support Grants$24.4M13%
  4. 12.420 · Military Medical Research and Development$20.9M11%
  5. 93.396 · Cancer Biology Research$16.8M8.9%
  6. 93.855 · Allergy and Infectious Diseases Research$10.1M5.3%
  7. 93.398 · Cancer Research Manpower$8.8M4.6%
  8. 93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research$7.2M3.8%

Awarding agencies

  1. Department of Health and Human Services
  2. Department of Defense
  3. Department of Health and Human Services

Largest awards

  1. 93.397 · Cancer Centers Support Grants· National Institutes of Health· Project grant· Nov 10, 2020 – May 7, 2026· P30CA006516
  2. 93.395 · Cancer Treatment Research· National Institutes of Health· Cooperative agreement· Oct 30, 2020 – Sep 10, 2026· U10CA180794
  3. 93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Oct 21, 2020 – Sep 7, 2026· P01CA066996
  4. 93.397 · Cancer Centers Support Grants· National Institutes of Health· Project grant· Feb 18, 2021 – Jan 2, 2026· P50CA127003
  5. 93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Feb 2, 2021 – Sep 17, 2026· P01CA155258
  6. 93.394 · Cancer Detection and Diagnosis Research· National Institutes of Health· Cooperative agreement· Jul 28, 2021 – Sep 17, 2026· U24CA233243

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2021–FY2026.

Subawards

Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.

As a prime: who it pays · FY2026

  • Sub-grants: $10M (70 subawards)

31 sub-recipients

  1. BOSTON, MA · 13 subawards
  2. CAMBRIDGE, MA · 7 subawards
  3. BOSTON, MA · 6 subawards
  4. BOSTON, MA · 6 subawards
  5. MINNEAPOLIS, MN · 1 subaward
  6. CAMBRIDGE, MA · 3 subawards
  7. NASHVILLE, TN · 2 subawards
  8. SAN FRANCISCO, CA · 5 subawards
  9. BOSTON, MA · 3 subawards
  10. SCOTTSDALE, AZ · 1 subaward

As a sub-recipient: who pays it · FY2026

  • Sub-grants: $18.9M (102 subawards)

43 primes

  1. CAMBRIDGE, MA · 11 subawards
  2. OAKLAND, CA · 9 subawards
  3. PITTSBURGH, PA · 2 subawards
  4. BOSTON, MA · 10 subawards
  5. SAN ANTONIO, TX · 2 subawards
  6. WASHINGTON, DC · 1 subaward
  7. AURORA, CO · 5 subawards
  8. VERMILLION, SD · 1 subaward
  9. NEW YORK, NY · 1 subaward
  10. SARC$632.2K3.3%
    ANN ARBOR, MI · 1 subaward

By fiscal year

  • FY2021: $35.4M paid out · $19.8M received
  • FY2022: $35.2M paid out · $21M received
  • FY2023: $36.9M paid out · $23.6M received
  • FY2024: $34.2M paid out · $23.1M received
  • FY2025: $23.2M paid out · $31.2M received
  • FY2026: $10M paid out · $18.9M received
  • FY2027: $0 paid out · $2.1M received

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 10, 2026, loaded Oct 10, 2026 · Subawards loaded from FY2021.

Teaming partners

Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.

Companies it pays

142 companies · $174.7M reported

  1. CAMBRIDGE, MA · 84 subawards
  2. PHILADELPHIA, PA · 16 subawards
  3. BOSTON, MA · 95 subawards

Primes that pay it

96 companies · $140.7M reported

  1. BOSTON, MA · 61 subawards · Scientific research and development services
  2. BOSTON, MA · 14 subawards
  3. BOSTON, MA · 111 subawards

Showing the top 3 of each list. Open the profile for potential partners and the full lists.

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 10, 2026, loaded Oct 10, 2026 · Subawards loaded from 2021.

Lobbying and PAC activity

Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.

Matched organizations

  • Dana-Farber Cancer InstituteAI match · 100%
Lobbying · 2025
$293.7K
8 reports
Lobbying · 2023–2026
$864K
$864K in its own reports

Lobbying by year

  1. 2023$212.3K
    8 reports
  2. 2024$271.9K
    8 reports
  3. 2025$293.7K
    8 reports
  4. 2026$86K
    4 reports

Top issues

  1. Health issues27 reports
  2. Medicare and Medicaid27 reports
  3. Medical and disease research, clinical labs23 reports
  4. Budget and appropriations14 reports
  5. Tobacco11 reports
  6. Civil rights and civil liberties8 reports
  7. Immigration8 reports

Who was contacted

  1. U.S. HOUSE OF REPRESENTATIVES27 reports
  2. U.S. SENATE27 reports

Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).

Lobbying firms hired

  1. ALSTON & BIRD LLP$480K
    14 reports

Registrants who are individuals are counted, not named.

Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 10, 2026, loaded Oct 10, 2026 · 2023–2026.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 10, 2026, loaded Oct 10, 2026 · 2026, 2024, 2022.

Matches: Analisa AI name judgments (entity-match@1), updated Oct 5, 2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026.